CordenPharma was created in 2006 as a privately held pharmaceutical brand of International Chemical Investors Group (ICIG). With 8 cGMP facilities across Europe and the US, CordenPharma is headed by a Leadership Team which includes the CordenPharma Executive Leadership Team, CordenPharma International Platform Directors, and CordenPharma Facility Managing Directors.

CordenPharma Executive Leadership Team

Dr. Riku Rautsola

Chief Executive Officer & President,

Dr. Walter Kittl

Chief Operating Officer,

Heiko Serwe

Chief Financial Officer,

Dr. Michael Quirmbach

Chief Business Officer,
CordenPharma International

Dr. Macniell Esua

Chief Compliance Officer,
CordenPharma International

CordenPharma International Technology Platform Directors

Jason Bertola

Director, Global Highly Potent & Oncology Platform,
CordenPharma International

Dr. Stephen Houldsworth

Director, Global Small Molecules & Antibiotics Platforms,
CordenPharma International

Dr. Matthieu Giraud

Director, Global Peptides, Lipids & Carbohydrates Platform, CordenPharma International

Fabio Stevanon

Director, Global Injectables Platform,
CordenPharma International

CordenPharma Facility Managing Directors

Laura Coppi

Managing Director,
CordenPharma Bergamo

Brian McCudden

Managing Director, President & CEO,
CordenPharma Boulder
& CordenPharma Colorado

Jan Braes

Managing Director,
CordenPharma Brussels

Fabrizio Fiordigiglio

Managing Director,
CordenPharma Caponago

Yves Michon

Managing Director,
CordenPharma Chenôve

Dr. Riku Rautsola

Acting Managing Director,
CordenPharma Plankstadt

Dr. Juerg Burger

Managing Director,
CordenPharma Switzerland